These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751 [TBL] [Abstract][Full Text] [Related]
29. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Lehmann P Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691 [TBL] [Abstract][Full Text] [Related]
30. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. Ortiz-Policarpio B; Lui H Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473 [TBL] [Abstract][Full Text] [Related]
31. How we treat Bowen's disease with topical photodynamic therapy in Dundee. Attili SK; Ibbotson SH Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):41-5. PubMed ID: 19447370 [TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy: update 2006. Part 2: Clinical results. Calzavara-Pinton PG; Venturini M; Sala R J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):439-51. PubMed ID: 17373968 [TBL] [Abstract][Full Text] [Related]
33. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. Braathen LR; Szeimies RM; Basset-Seguin N; Bissonnette R; Foley P; Pariser D; Roelandts R; Wennberg AM; Morton CA; J Am Acad Dermatol; 2007 Jan; 56(1):125-43. PubMed ID: 17190630 [TBL] [Abstract][Full Text] [Related]
34. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy. Fai D; Romano I; Fai C; Cassano N; Vena GA G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493 [TBL] [Abstract][Full Text] [Related]
35. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer. Goldberg LH; Landau JM; Moody MN; Marquez D; Jih M; Kimyai-Asadi A; Friedman PM; Busch A; Vergilis-Kalner IJ J Drugs Dermatol; 2012 May; 11(5):593-7. PubMed ID: 22527427 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis. Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]